Open-Label Study of Leuco-methylthioninium Bis(Hydromethanesulfonate) (LMTM) in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)

NCT02245568 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
913
Enrollment
INDUSTRY
Sponsor class

Stopped This study has been terminated for administrative reasons only.

Conditions

Interventions

Sponsor

TauRx Therapeutics Ltd